TABLE 1.
Characteristics of 52 patients included in the study
| Variable | Value |
|---|---|
| age (yrs) | |
| median | 6.5 |
| mean | 7.7 |
| range | 1–17 |
| sex (%) | |
| male | 32 (62) |
| female | 20 (38) |
| follow-up | |
| mean yrs | 10.02 |
| no. w/ <5 yrs | 11 |
| no. w/ 5–10 yrs | 15 |
| no. w/ 10–15 yrs | 12 |
| no. w/ >15 yrs | 14 |
| race (%) | |
| white | 41 (79) |
| black | 8 (15) |
| other | 3 (6) |
| neurofibromatosis (%) | 2 (4) |
| presentation (%)* | |
| increased intracranial pressure | 27 (52) |
| unilateral hemiparesis | 13 (25) |
| unilateral cranial neuropathy | 9 (17) |
| ataxia | 15 (29) |
| hydrocephalus | 19 (37) |
| tumor location (%) | |
| midbrain | 22 (42) |
| pons | 15 (29) |
| medulla | 15 (29) |
| tumor appearance (%) | |
| intrinsic | 26 (50) |
| exophytic | 26 (50) |
| tumor grade (%) | |
| I | 42 (81) |
| II | 10 (19) |
| extent of surgery (%) | |
| biopsy | 17 (33) |
| GTR | 9 (17) |
| NTR | 17 (33) |
| STR | 9 (17) |
| mode of treatment (%) | |
| surgery only | 25 (48) |
| radiation only | 14 (27) |
| surgery + radiation | 7 (13) |
| surgery + chemotherapy | 2 (4) |
| surgery + radiation + chemotherapy | 1 (2) |
| chemotherapy only | 2 (4) |
| chemotherapy + radiation | 1 (2) |
*
Numbers do not sum to 52 because patients may have had more than 1 presenting element.